These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 21908431)

  • 1. Major histocompatibility complex class II expression deficiency caused by a RFXANK founder mutation: a survey of 35 patients.
    Ouederni M; Vincent QB; Frange P; Touzot F; Scerra S; Bejaoui M; Bousfiha A; Levy Y; Lisowska-Grospierre B; Canioni D; Bruneau J; Debré M; Blanche S; Abel L; Casanova JL; Fischer A; Picard C
    Blood; 2011 Nov; 118(19):5108-18. PubMed ID: 21908431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical, Immunological, and Genetic Findings in Iranian Patients with MHC-II Deficiency: Confirmation of c.162delG RFXANK Founder Mutation in the Iranian Population.
    Mousavi Khorshidi MS; Seeleuthner Y; Chavoshzadeh Z; Behfar M; Hamidieh AA; Alimadadi H; Sherkat R; Momen T; Behniafard N; Eskandarzadeh S; Mansouri M; Behnam M; Mahdavi M; Heydarazad Zadeh M; Shokri M; Alizadeh F; Movahedi M; Momenilandi M; Keramatipour M; Casanova JL; Cobat A; Abel L; Shahrooei M; Parvaneh N
    J Clin Immunol; 2023 Nov; 43(8):1941-1952. PubMed ID: 37584719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 752delG26 mutation in the RFXANK gene associated with major histocompatibility complex class II deficiency: evidence for a founder effect in the Moroccan population.
    Naamane H; El Maataoui O; Ailal F; Barakat A; Bennani S; Najib J; Hassar M; Saile R; Bousfiha AA
    Eur J Pediatr; 2010 Sep; 169(9):1069-74. PubMed ID: 20414676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MHC Class II Deficiency: Clinical, Immunological, and Genetic Insights in a Large Multicenter Cohort.
    Gulec Koksal Z; Bilgic Eltan S; Topyildiz E; Sezer A; Keles S; Celebi Celik F; Ozhan Kont A; Gemici Karaaslan B; Sefer AP; Karali Z; Arik E; Ozek Yucel E; Akcal O; Karakurt LT; Yorgun Altunbas M; Yalcin K; Uygun V; Ozek G; Babayeva R; Aydogmus C; Ozcan D; Cavkaytar O; Keskin O; Kilic SS; Kiykim A; Arikoglu T; Genel F; Gulez N; Guner SN; Karaca NE; Reisli I; Kutukculer N; Altintas DU; Ozen A; Karakoc Aydiner E; Baris S
    J Allergy Clin Immunol Pract; 2024 Sep; 12(9):2490-2502.e6. PubMed ID: 38996837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Founder effect for a 26-bp deletion in the RFXANK gene in North African major histocompatibility complex class II-deficient patients belonging to complementation group B.
    Wiszniewski W; Fondaneche MC; Lambert N; Masternak K; Picard C; Notarangelo L; Schwartz K; Bal J; Reith W; Alcaide C; de Saint Basile G; Fischer A; Lisowska-Grospierre B
    Immunogenetics; 2000 Apr; 51(4-5):261-7. PubMed ID: 10803838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical, Immunological, and Molecular Findings in Five Patients with Major Histocompatibility Complex Class II Deficiency from India.
    Aluri J; Gupta M; Dalvi A; Mhatre S; Kulkarni M; Hule G; Desai M; Shah N; Taur P; Vedam R; Madkaikar M
    Front Immunol; 2018; 9():188. PubMed ID: 29527204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel mutations in the RFXANK gene: RFX complex containing in-vitro-generated RFXANK mutant binds the promoter without transactivating MHC II.
    Wiszniewski W; Fondaneche MC; Louise-Plence P; Prochnicka-Chalufour A; Selz F; Picard C; Le Deist F; Eliaou JF; Fischer A; Lisowska-Grospierre B
    Immunogenetics; 2003 Feb; 54(11):747-55. PubMed ID: 12618906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel mutation in RFXANK gene and low B cell count in a patient with MHC class II deficiency: a case report.
    Abolnezhadian F; Dehghani R; Dehnavi S; Khodadadi A; Shohan M
    Immunol Res; 2020 Aug; 68(4):225-231. PubMed ID: 32578129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical, immunological and genetic findings of a large tunisian series of major histocompatibility complex class II deficiency patients.
    Ben-Mustapha I; Ben-Farhat K; Guirat-Dhouib N; Dhemaied E; Larguèche B; Ben-Ali M; Chemli J; Bouguila J; Ben-Mansour L; Mellouli F; Khemiri M; Béjaoui M; Barbouche MR
    J Clin Immunol; 2013 May; 33(4):865-70. PubMed ID: 23314770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical, immunological and genetic features in eleven Algerian patients with major histocompatibility complex class II expression deficiency.
    Djidjik R; Messaoudani N; Tahiat A; Meddour Y; Chaib S; Atek A; Khiari ME; Benhalla NK; Smati L; Bensenouci A; Baghriche M; Ghaffor M
    Allergy Asthma Clin Immunol; 2012 Aug; 8(1):14. PubMed ID: 22863278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Major histocompatibility complex class II deficiency in Kuwait: clinical manifestations, immunological findings and molecular profile.
    Al-Herz W; Alsmadi O; Melhem M; Recher M; Frugoni F; Notarangelo LD
    J Clin Immunol; 2013 Apr; 33(3):513-9. PubMed ID: 23143406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uncoordinated HLA-D gene expression in a RFXANK-defective patient with MHC class II deficiency.
    Lennon-Duménil AM; Barbouche MR; Vedrenne J; Prod'Homme T; Béjaoui M; Ghariani S; Charron D; Fellous M; Dellagi K; Alcaïde-Loridan C
    J Immunol; 2001 May; 166(9):5681-7. PubMed ID: 11313409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Major Histocompatibility Complex Class II Deficiency due to a Novel Mutation in RFXANK in a Child of Mexican Descent.
    Clarridge K; Leitenberg D; Loechelt B; Picard C; Keller M
    J Clin Immunol; 2016 Jan; 36(1):4-5. PubMed ID: 26634365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular genetics of the Bare lymphocyte syndrome.
    Masternak K; Muhlethaler-Mottet A; Villard J; Peretti M; Reith W
    Rev Immunogenet; 2000; 2(2):267-82. PubMed ID: 11258423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Major histocompatibility complex class II deficiency: clinical manifestations, immunologic features, and outcome.
    Klein C; Lisowska-Grospierre B; LeDeist F; Fischer A; Griscelli C
    J Pediatr; 1993 Dec; 123(6):921-8. PubMed ID: 8229525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MHC class II deficiency: Report of a novel mutation and special review.
    Farrokhi S; Shabani M; Aryan Z; Zoghi S; Krolo A; Boztug K; Rezaei N
    Allergol Immunopathol (Madr); 2018; 46(3):263-275. PubMed ID: 28676232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MHC-II Deficiency Among Egyptians: Novel Mutations and Unique Phenotypes.
    El Hawary RE; Mauracher AA; Meshaal SS; Eldash A; Abd Elaziz DS; Alkady R; Lotfy S; Opitz L; Galal NM; Boutros JA; Pachlopnik Schmid J; Elmarsafy AM
    J Allergy Clin Immunol Pract; 2019 Mar; 7(3):856-863. PubMed ID: 30170160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A gene encoding a novel RFX-associated transactivator is mutated in the majority of MHC class II deficiency patients.
    Masternak K; Barras E; Zufferey M; Conrad B; Corthals G; Aebersold R; Sanchez JC; Hochstrasser DF; Mach B; Reith W
    Nat Genet; 1998 Nov; 20(3):273-7. PubMed ID: 9806546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MHC Class II Deficiency with Normal CD4+ T Cell Counts: A Case Report.
    Abolnezhadian F; Saeedi-Boroujeni A; Iranparast S
    Iran J Allergy Asthma Immunol; 2018 Dec; 17(6):594-600. PubMed ID: 30644704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MHC class II deficiency cured by unrelated mismatched umbilical cord blood transplantation: case report and review of 68 cases in the literature.
    Siepermann M; Gudowius S; Beltz K; Strier U; Feyen O; Troeger A; Göbel U; Laws HJ; Kögler G; Meisel R; Dilloo D; Niehues T
    Pediatr Transplant; 2011 Jun; 15(4):E80-6. PubMed ID: 20214747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.